Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
Reactions of anthralin with peroxidizing lipids were investigated. Using ESR spectroscopy and quantitative HPLC analysis radical species and decomposition products respectively were analysed in the reaction mixture as a function of time. Directly after mixing anthralin with peroxidized lipids, the 1,8-dihydroxy-9-anthron-10-yl radicals (primary radical) and small amounts of 1,8-dihydroxy-anthraquinone (AQ) were formed. After a few days of reaction, two secondary radicals were observed in addition to the primary radical. At the same time, 1,8,1'8'-tetrahydroxy-10,10'-bis-9(10H)-anthrone (DI) and an increasing amount of AQ and other nonidentified decomposition products were found. As the reaction proceeded further on the amount of AQ and the nonidentified decomposition products increased, the primary radical disappeared (within about 40 d) and the concentration of DI decreased to zero (within 1 yr). Nonidentified decomposition products are tentatively assigned to polymeric degradation products (anthralin brown) formed from DI via the observed secondary radical species. These radical reactions of anthralin with peroxidized lipids help to elucidate speculations on radical type reactions of anthralin in psoriasis indications, e.g., the role of peroxidized skin lipids as radical reaction initiators.
D000818:Animals; D000873:Anthracenes / Q000494:pharmacology*; D000875:Anthralin / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D002645:Chickens; D005609:Free Radicals; D006801:Humans; D066298:In Vitro Techniques; D008054:Lipid Peroxides / Q000378:metabolism*; D010084:Oxidation-Reduction; D011565:Psoriasis / Q000188:drug therapy*; D012867:Skin / Q000378:metabolism
D000873:Anthracenes; D005609:Free Radicals; D008054:Lipid Peroxides; D000875:Anthralin